ADT Pharmaceuticals, LLC
Records under this name other than patents ADT Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to ADT Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,862,698 | Indenyl Compounds, Pharmaceutical Compositions, and Medical Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,526,307 | Indenyl Compounds, Pharmaceutical Compositions, and Medical Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,975,054 | Indenyl compounds, pharmaceutical compositions, and medical uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,981,886 | Indenyl Compounds, Pharmaceutical Compositions, and Medical Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,479,813 | Method of Therapeutically Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,680,073 | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,407,727 | Indenyl Compounds, Pharmaceutical Compositions, and Medical Uses Thereof Formerly held Lapsed on the fee record Ended Aug 9, 2026 · High confidence | Lapsed on the fee record | Ended Aug 9, 2026 | High confidence |
| US 9,931,315 | Method of selectively inhibiting Ras-mediated tumor growth in humans Lapsed on the fee record Ended Apr 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2026 | From the USPTO record |
| US 11,198,679 | Method of treating or preventing Ras-mediated diseases Lapsed on the fee record Ended Dec 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 14, 2025 | From the USPTO record |
| US 11,186,596 | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses Lapsed on the fee record Ended Nov 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 30, 2025 | From the USPTO record |